Clementia Pharmaceuticals Inc.
Overview
Clementia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for rare diseases. It operates as a subsidiary of Ipsen, a global biopharmaceutical group.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Clementia Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Verified Supplier Partner
Is this Clementia Pharmaceuticals Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
ApoPharma Inc.
Canada
ACHN Pharmaceuticals Inc.
USA
Blueprint Medicines Corporation
United States
Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi)
United States
Forma Therapeutics Holdings, Inc.
United States
3P Biopharmaceuticals S.L.
Spain
Acceleron Pharma Inc.
United States
Ace Pharmaceuticals B.V.
Netherlands
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.